Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.925
-0.085 (-8.42%)
May 3, 2024, 3:58 PM EDT - Market closed
Arch Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 4 | 4 | 5 | 29 | 33 | 40 | 61 | 116 | 83 | 22 | 12 | Upgrade
|
| Market Cap Growth | - | -13.24% | -83.89% | -12.22% | -18.39% | -34.65% | -47.16% | 39.97% | 282.92% | 77.55% | 67.23% | Upgrade
|
| Enterprise Value | 11 | 10 | 7 | 28 | 32 | 38 | 56 | 110 | 79 | 19 | 12 | Upgrade
|
| PE Ratio | -3.18 | -0.57 | -1.08 | -4.35 | -8.12 | -14.66 | -12.69 | -14.84 | -13.78 | -7.32 | -1.49 | Upgrade
|
| PS Ratio | 38.04 | 52.78 | 294.30 | 2472.99 | - | - | - | - | - | - | - | Upgrade
|
| PB Ratio | -3.56 | -0.53 | -1.10 | -27.88 | -21.71 | -49.45 | 44.92 | 51.92 | 26.13 | 14.01 | -1.76 | Upgrade
|
| P/FCF Ratio | -9.49 | -1.18 | -1.03 | -4.80 | -6.46 | -7.58 | -10.30 | -20.55 | -17.40 | -5.09 | -3.63 | Upgrade
|
| P/OCF Ratio | -9.50 | -1.18 | -1.03 | -4.80 | -6.46 | -7.58 | -10.33 | -20.58 | -17.40 | -5.09 | -3.63 | Upgrade
|
| EV/Sales Ratio | 99.39 | 127.37 | 461.39 | 2415.35 | - | - | - | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | -7.82 | -1.91 | -1.27 | -4.51 | -5.35 | -4.61 | -7.58 | -15.01 | -12.98 | -3.49 | -2.66 | Upgrade
|
| EV/EBIT Ratio | -7.82 | -1.91 | -1.27 | -4.51 | -5.35 | -4.60 | -7.57 | -15.01 | - | - | -2.66 | Upgrade
|
| EV/FCF Ratio | -11.46 | -2.85 | -1.62 | -4.69 | -6.41 | -7.16 | -9.52 | -19.49 | -16.54 | -4.49 | -3.66 | Upgrade
|
| Debt / Equity Ratio | -1.20 | -0.78 | -0.80 | -2.53 | -0.48 | 0 | 0 | 0 | 0.31 | 0.94 | -0.14 | Upgrade
|
| Debt / EBITDA Ratio | -1.38 | -1.16 | -0.59 | -0.26 | -0.12 | - | - | - | -0.16 | -0.26 | -0.21 | Upgrade
|
| Debt / FCF Ratio | -2.03 | -1.74 | -0.75 | -0.27 | -0.14 | - | - | - | -0.21 | -0.34 | -0.29 | Upgrade
|
| Quick Ratio | 0.02 | 0.02 | 0.22 | 1.31 | 1.48 | 3.05 | 16.18 | 13.83 | 2.68 | 3.08 | 0.31 | Upgrade
|
| Current Ratio | 0.16 | 0.21 | 0.78 | 2.12 | 3.32 | 4.05 | 16.71 | 14.02 | 2.74 | 3.11 | 0.32 | Upgrade
|
| Asset Turnover | 0.06 | 0.04 | 0.01 | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | -1.26 | -1.63 | -10.07 | -42.36 | -298.37 | 0 | 0 | -139.40 | -21.87 | -14.45 | -41.53 | Upgrade
|
| Return on Equity (ROE) | 83.30% | 93.01% | 101.98% | 640.48% | 267.39% | 337.35% | -354.02% | -349.82% | -189.57% | -191.38% | 118.14% | Upgrade
|
| Return on Assets (ROA) | -437.81% | -356.60% | -164.22% | -178.68% | -186.52% | -93.84% | -99.46% | -127.89% | -116.49% | -73.63% | -928.50% | Upgrade
|
| Return on Capital (ROIC) | 229.53% | 308.22% | 687.37% | -1110.37% | 693.71% | 789.27% | -547.85% | -327.98% | -146.19% | -183.20% | 77.68% | Upgrade
|
| Earnings Yield | -181.84% | -174.73% | -92.82% | -22.97% | -12.31% | -6.82% | -7.88% | -6.74% | -7.26% | -13.67% | -67.03% | Upgrade
|
| FCF Yield | -81.87% | -84.55% | -96.74% | -20.85% | -15.49% | -13.20% | -9.71% | -4.87% | -5.75% | -19.65% | -27.56% | Upgrade
|
| Buyback Yield / Dilution | -276.77% | -156.27% | -9.05% | -16.99% | -13.05% | -8.92% | -7.00% | -17.50% | -49.23% | -20.60% | -215.88% | Upgrade
|
| Total Shareholder Return | -276.77% | -156.27% | -9.05% | -16.99% | -13.05% | -8.92% | -7.00% | -17.50% | -49.23% | -20.60% | -215.88% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.